ProCE Banner Activity

Ending the HIV Epidemic: Keys to Successful Treatment Initiation

Podcast Episodes
Listen to Chloe Orkin, MBChB, FRCP, MD, discuss why HIV treatment initiation is such a crucial part of putting an end to HIV, and hear patient perspectives on the difference that rapid ART initiation can make on a personal level.

Released: August 24, 2022

Expiration: August 23, 2023

No longer available for credit.

Share

Faculty

Nagalingeswaran Kumarasamy

Nagalingeswaran Kumarasamy, MBBS, FRCP, PhD

Chief & Director
VHS-Infectious Diseases Medical Centre
Director
Chennai Antiviral Research and Treatment (CART) Clinical Research Site
Voluntary Health Services
Chennai, India

Chloe Orkin

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Faculty of Medicine and Dentistry
Queen Mary University of London
London, United Kingdom

Babafemi Taiwo

Babafemi Taiwo, MBBS

Assistant Professor
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Nagalingeswaran Kumarasamy, MBBS, FRCP, PhD

Chief & Director
VHS-Infectious Diseases Medical Centre
Director
Chennai Antiviral Research and Treatment (CART) Clinical Research Site
Voluntary Health Services
Chennai, India

Nagalingeswaran Kumarasamy, MBBS, FRCP, PhD, has no relevant financial relationships to disclose.

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Faculty of Medicine and Dentistry
Queen Mary University of London
London, United Kingdom

Chloe Orkin, MBChB, FRCP, MD: consultant/advisor/speaker: Gilead Sciences, Janssen, MSD, ViiV Healthcare; researcher: Gilead Sciences, Janssen, MSD, ViiV Healthcare.

Babafemi Taiwo, MBBS

Assistant Professor
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Babafemi Taiwo, MBBS: consultant/advisor/speaker: Gilead Sciences, GlaxoSmithKline, Johnson and Johnson, ViiV Healthcare.